Jiangsu Jibeier Pharmaceutical Investor Relations Material
Latest events
Q4 2024
15 Apr, 2025
Q3 2024
26 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Jiangsu Jibeier Pharmaceutical
Access all reports
Jiangsu Jibeier Pharmaceutical Co., Ltd. is a China-based pharmaceutical company engaged in the research, development, production, and sale of pharmaceutical products. The company specializes in treatments for chronic and infectious diseases, providing a portfolio of products that includes antibiotics, antiviral drugs, and health supplements. The company is headquartered in Suzhou, China, and its shares are listed on the Shanghai Stock Exchange.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
688566
Country
🇨🇳 China